Machida Y - Search Results

1

Soluble Fms-like tyrosine kinase 1 is a novel predictor of brain natriuretic peptide elevation.

Kameda R, Yamaoka-Tojo M, Makino A, Wakaume K, Nemoto S, Kitasato L, Shimohama T, Tojo T, Machida Y, Izumi T. Kameda R, et al. Among authors: machida y. Int Heart J. 2013;54(3):133-9. doi: 10.1536/ihj.54.133. Int Heart J. 2013. PMID: 23774235 Free article.

2

C-reactive protein-induced production of interleukin-18 in human endothelial cells: a mechanism of orchestrating cytokine cascade in acute coronary syndrome.

Yamaoka-Tojo M, Tojo T, Masuda T, Machida Y, Kitano Y, Kurosawa T, Izumi T. Yamaoka-Tojo M, et al. Among authors: machida y. Heart Vessels. 2003 Sep;18(4):183-7. doi: 10.1007/s00380-003-0719-7. Heart Vessels. 2003. PMID: 14520485

3

Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure.

Yamaoka-Tojo M, Tojo T, Inomata T, Machida Y, Osada K, Izumi T. Yamaoka-Tojo M, et al. Among authors: machida y. J Card Fail. 2002 Feb;8(1):21-7. doi: 10.1054/jcaf.2002.31628. J Card Fail. 2002. PMID: 11862579

4

Rapamycin ameliorates experimental autoimmune myocarditis.

Maeda K, Shioi T, Kosugi R, Yoshida Y, Takahashi K, Machida Y, Izumi T. Maeda K, et al. Among authors: machida y. Int Heart J. 2005 May;46(3):513-30. doi: 10.1536/ihj.46.513. Int Heart J. 2005. PMID: 16043946 Free article.

5

Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia.

Yamaoka-Tojo M, Tojo T, Kosugi R, Hatakeyama Y, Yoshida Y, Machida Y, Aoyama N, Masuda T, Izumi T. Yamaoka-Tojo M, et al. Among authors: machida y. Lipids Health Dis. 2009 Oct 12;8:41. doi: 10.1186/1476-511X-8-41. Lipids Health Dis. 2009. PMID: 19821987 Free PMC article.

6

Angiotensin II receptor antagonist attenuates expression of aging markers in diabetic mouse heart.

Kosugi R, Shioi T, Watanabe-Maeda K, Yoshida Y, Takahashi K, Machida Y, Izumi T. Kosugi R, et al. Among authors: machida y. Circ J. 2006 Apr;70(4):482-8. doi: 10.1253/circj.70.482. Circ J. 2006. PMID: 16565569 Free article.

7

Resuscitation from fulminant myocarditis associated with refractory ventricular fibrillation.

Kohno K, Aoyama N, Shimohama T, Yoshida M, Machida Y, Fukuda N, Aizaki T, Suzuki K, Kurosawa T, Izumi T. Kohno K, et al. Among authors: machida y. Jpn Circ J. 2000 Feb;64(2):139-43. doi: 10.1253/jcj.64.139. Jpn Circ J. 2000. PMID: 10716529 Free article.

8

N-acetylcysteine suppresses the progression of ventricular remodeling in acute myocarditis: studies in an experimental autoimmune myocarditis (EAM) model.

Niwano S, Niwano H, Sasaki S, Fukaya H, Yuge M, Imaki R, Machida Y, Izumi T. Niwano S, et al. Among authors: machida y. Circ J. 2011;75(3):662-71. doi: 10.1253/circj.cj-10-0673. Epub 2010 Dec 24. Circ J. 2011. PMID: 21187656 Free article.

9

Effect of persistent activation of phosphoinositide 3-kinase on heart.

Niizuma S, Inuzuka Y, Okuda J, Kato T, Kawashima T, Tamaki Y, Iwanaga Y, Yoshida Y, Kosugi R, Watanabe-Maeda K, Machida Y, Tsuji S, Aburatani H, Izumi T, Kita T, Kimura T, Shioi T. Niizuma S, et al. Among authors: machida y. Life Sci. 2012 Apr 20;90(15-16):619-28. doi: 10.1016/j.lfs.2012.02.010. Epub 2012 Feb 25. Life Sci. 2012. PMID: 22391413

10

Immunomodulatory effect of pentoxifylline in suppressing experimental autoimmune myocarditis.

Takehana H, Inomata T, Niwano H, Nishii M, Matsuda C, Kohno K, Machida Y, Izumi T. Takehana H, et al. Among authors: machida y. Circ J. 2002 May;66(5):499-504. doi: 10.1253/circj.66.499. Circ J. 2002. PMID: 12030348 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

860 results

Search Page